Our responsibility Your (patients) health

In 2020 some 500 million people worldwide were affected by osteoarthritis.

According to the world-renowned medical journal, — The Lancet

a 21st century challenge

An ageing and overweight population only serves to exacerbate the situation. By 2050, 16% of the world’s population will be over 65. Overweight people are 4 to 5 times more likely to suffer from arthritis. It’s also the fit and healthy who can suffer. In a panel of 284 professional athletes interviewed, almost 50% were found to have osteoarthritis.

Tell-tale signs of osteoarthritis are joint (hand, knee, hip) stiffness in the morning, joint pain (whether active or inactive), swelling, tender and warm joints, and limited range of movement.

Viscosupplementation (intra-articular injection of hyaluronic acid) continues to be the most convenient and common treatment available

Synolis VA is a premium innovative product which meets both patients and doctors expectations.

Aptissen revolutionized the market by launching the first HA product of the 2nd generation: Synolis VA which combines Hyaluronic Acid and Sorbitol, an antioxidant. Synolis VA’s viscoelastic properties (a patented formulation) are similar to those found in young, healthy synovial fluid. This results in rapid mobility recovery and fast, long-lasting pain relief associated with excellent safety. As such, Synolis VA is a premium innovative product which meets both patients and doctors expectations.

Read more about Synolis VA

our vision

We are committed to our vision of a world free from musculoskeletal pain

Our very raison d’être is pain relief for our patients. We pride ourselves in deliver life-changing orthobiologic solutions. As a proudly Swiss company, we’re committed to proven products and guiding our partners with wise counsel.

See our products

Keep informed

Latest news

Newsroom 01.08.2021

New Aptissen Website

Webinars 23.07.2021

Three-Dimensional Kinematic Analysis for Patients with Knee Osteoarthritis

Webinars 07.07.2021

Advancing Intra Articular Therapy For Osteoarthritis: Experience, Innovations and Improving Patient Outcomes

Newsroom 01.07.2021

In order to continue the exponential growth, Aptissen has expanded its management team.

Events 22.06.2021

Aptissen was thrilled to welcome global partners in the frame of the Arab Health 2021 at the Palazzo Versace hotel on Tuesday 22nd June.

Events 18.06.2021

On Friday 18 and Saturday 19 June, Aptissen Italia participated in the XX NATIONAL CONGRESS SICOOP.

This site is registered on wpml.org as a development site.